Abstract Details
Kimberly Ifantides
PRESENTER |
No disclosure on file |
Erin McGonigle, MD | No disclosure on file |
No disclosure on file | |
Alberto Esquenazi, MD (Department of Physical Medicine and Rehabilitation) | Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz. |
No disclosure on file | |
Monica Verduzco-Gutierrez (UT Health San Antonio) | No disclosure on file |
Amin Boroujerdi, PhD (Allergan R&D) | No disclosure on file |
Adam Buser, PhD (Allergan) | Dr. Buser has received personal compensation for serving as an employee of AbbVie. Dr. Buser has received stock or an ownership interest from AbbVie. |
No disclosure on file | |
No disclosure on file | |
Aleksej Zuzek, PhD (Allergan) | Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc.. |